Financials
- Market Capitalization 8.43 B
- Employee 691
- Founded 2014
- CEO Rich Adcock
- Website www.immunitybio.com
- Headquarter Delaware, United States
- FIGI BBG007T9DYW9
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-9.03
市销率
52.32
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 992 | ABVX Abivax SA - American Depositary Shares | 111.73 USD | -1.43% | -5.31% | -7.20% | +39.65% | 8.77 B USD | ||
| 1018 | APGE Apogee Therapeutics, Inc. - Common Stock | 135.08 USD | +0.08% | +0.17% | +0.72% | +152.06% | 8.40 B USD | ||
| 1025 | IMVT Immunovant, Inc. - Common Stock | 40.79 USD | -1.00% | -5.84% | +6.56% | +112.34% | 8.43 B USD | ||
| 1039 | TGTX TG Therapeutics, Inc. - Common Stock | 54.30 USD | +0.69% | -3.05% | +7.12% | +84.88% | 8.31 B USD |